You are here » Home » Companies » Company Overview » Biofil Chemicals & Pharmaceuticals Ltd

Biofil Chemicals & Pharmaceuticals Ltd.

BSE: 524396 Sector: Health care
NSE: BIOFILCHEM ISIN Code: INE829A01014
BSE 00:00 | 24 Feb 76.95 3.65
(4.98%)
OPEN

76.95

HIGH

76.95

LOW

76.95

NSE 00:00 | 24 Feb 78.15 3.70
(4.97%)
OPEN

78.15

HIGH

78.15

LOW

78.15

OPEN 76.95
PREVIOUS CLOSE 73.30
VOLUME 1573
52-Week high 352.45
52-Week low 6.55
P/E 69.32
Mkt Cap.(Rs cr) 125
Buy Price 76.95
Buy Qty 53319.00
Sell Price 76.95
Sell Qty 50.00
OPEN 76.95
CLOSE 73.30
VOLUME 1573
52-Week high 352.45
52-Week low 6.55
P/E 69.32
Mkt Cap.(Rs cr) 125
Buy Price 76.95
Buy Qty 53319.00
Sell Price 76.95
Sell Qty 50.00

Biofil Chemicals & Pharmaceuticals Ltd. (BIOFILCHEM) - Company History

Biofil Chemicals & Pharmaceuticals (BCPL) was incorporated as a private limited company on 4 Jan.'85 for manufacture of pharmaceutical products and it was converted into a public limited company on 7 May '92. It was promoted by the Systematix group and Ramesh Shah of the Cyano group. Ramesh Shah is the chairman and managing director and Anand Kumar Sethiya is the managing director. In Feb.'96 the company had come out with a rights-cum-public issue at a premium of Rs 7.50 and at a premium of Rs 12.50 respectively both aggregating Rs 23.21 cr to part-finance its expansion and diversification into bulk drugs and pharmaceutical formulations. The company currently manufactures pharmaceutical formulations like injections capsules eye-drops and dry syrups at its plant located in Indore. BCPL's new unit is being set up at Pithampur in Madhya Pradesh at a project cost of Rs 39.75 cr and will manufacture bulk drugs like astemizole cefaclor pentazocine cefazolin sodium and cefotoxime sodium. It is also setting up a R&D centre which will include a pilot plant for bulk drugs and separate sections for formulations development and will house modern analytical instruments.During the year 1999-2000 the company had achieved a turnover of Rs.1164.03 lakhs.

.